Shuo Li

2.3k total citations · 1 hit paper
53 papers, 1.6k citations indexed

About

Shuo Li is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Shuo Li has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 21 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Shuo Li's work include Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (8 papers). Shuo Li is often cited by papers focused on Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (8 papers). Shuo Li collaborates with scholars based in China, Australia and United States. Shuo Li's co-authors include Peter G. Tipping, Eric J. Gowans, Magdalena Plebanski, Stephen R. Holdsworth, Stephen R. Holdsworth, Claire Chougnet, Ulf Dittmer, Hideaki Morita, Avidan U. Neumann and Damir Zhakparov and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shuo Li

49 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

2020 387 citations Urszula Radzikowska, Mei Ding et al. Allergy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuo Li China	19	669	436	377	194	169	53	1.6k
Achille Broggi Italy	14	808 1.2×	571 1.3×	328 0.9×	236 1.2×	146 0.9×	17	1.4k
Mikkel‐Ole Skjoedt Denmark	26	1.6k 2.4×	337 0.8×	384 1.0×	265 1.4×	50 0.3×	64	2.2k
Alessandra Amendola Italy	24	394 0.6×	385 0.9×	534 1.4×	358 1.8×	117 0.7×	70	1.9k
Diana Wouters Netherlands	28	1.4k 2.1×	661 1.5×	195 0.5×	197 1.0×	158 0.9×	86	2.6k
Mieke C. Brouwer Netherlands	21	1.0k 1.5×	406 0.9×	155 0.4×	243 1.3×	129 0.8×	50	1.8k
Akihiko Numata Japan	23	607 0.9×	432 1.0×	89 0.2×	219 1.1×	476 2.8×	87	1.8k
Kazuko Yamazaki Japan	22	297 0.4×	610 1.4×	111 0.3×	130 0.7×	180 1.1×	66	1.5k
Patcharin Pramoonjago United States	23	492 0.7×	458 1.1×	264 0.7×	526 2.7×	66 0.4×	45	1.7k
Gabriela Fernández Argentina	26	745 1.1×	271 0.6×	282 0.7×	287 1.5×	137 0.8×	75	1.7k
Qigui Yu United States	26	588 0.9×	407 0.9×	269 0.7×	356 1.8×	151 0.9×	75	1.6k

Countries citing papers authored by Shuo Li

Since Specialization

Citations

This map shows the geographic impact of Shuo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Li more than expected).

Fields of papers citing papers by Shuo Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Li. The network helps show where Shuo Li may publish in the future.

Co-authorship network of co-authors of Shuo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Li. A scholar is included among the top collaborators of Shuo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Li. Shuo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Shan, Zhenhao Li, Weihua Huang, et al.. (2025). Functional phyto-nanozymes for dual regulation of microbial metabolism and overinflammation microenvironment in diabetic wound. Materials Today Bio. 35. 102293–102293.

Huang, Yu, Jialin Yang, Jiahao Li, et al.. (2025). Perception of viral infections and initiation of antiviral defence in rice. Nature. 641(8061). 173–181. 10 indexed citations

Li, Shuo, Xue Liu, Gang Liu, & Chao Liu. (2023). Biomimetic Nanotechnology for SARS-CoV-2 Treatment. Viruses. 15(3). 596–596. 6 indexed citations

Zhang, Xin, Wenxiang Cheng, Jing Qu, et al.. (2023). Peptide-based inhibitors hold great promise as the broad-spectrum agents against coronavirus. Frontiers in Microbiology. 13. 1093646–1093646. 8 indexed citations

Wang, Haiyan, et al.. (2022). Effects of Rehmannia 14 on Hormone Levels and Renal Function in Geriatric and Kidney Yang Deficiency Mice.

Huang, Chun‐Kai, Mingyao Meng, Shuo Li, et al.. (2022). Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway. Frontiers in Cell and Developmental Biology. 10. 876054–876054. 9 indexed citations

Hu, Xiao, Yanli Zou, David A. Copland, et al.. (2022). Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2. EBioMedicine. 86. 104333–104333. 8 indexed citations

Radzikowska, Urszula, Mei Ding, Ge Tan, et al.. (2020). Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors. Allergy. 75(11). 2829–2845. 387 indexed citations breakdown →

Yu, Changqing, Xianfeng Zhang, Iqbal Ahmad, et al.. (2020). MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation. mBio. 11(5). 42 indexed citations

10.

Huang, Huan, Shuo Li, Lizhou Sun, & Guohua Zhou. (2015). Digital Detection of Multiple Minority Mutants and Expression Levels of Multiple Colorectal Cancer-Related Genes Using Digital-PCR Coupled with Bead-Array. PLoS ONE. 10(4). e0123420–e0123420. 2 indexed citations

11.

Qin, Sida, Chengcheng Yang, Xifang Wang, et al.. (2012). Overexpression of Smac Promotes Cisplatin-Induced Apoptosis by Activating Caspase-3 and Caspase-9 in Lung Cancer A549 Cells. Cancer Biotherapy and Radiopharmaceuticals. 28(2). 177–182. 22 indexed citations

12.

Qin, Sida, Chengcheng Yang, Shuo Li, et al.. (2012). Smac: Its role in apoptosis induction and use in lung cancer diagnosis and treatment. Cancer Letters. 318(1). 9–13. 31 indexed citations

13.

Li, Shuo, Stuart K. Roberts, Magdalena Plebanski, et al.. (2012). Induction of Multi-Functional T Cells in a Phase I Clinical Trial of Dendritic Cell Immunotherapy in Hepatitis C Virus Infected Individuals. PLoS ONE. 7(8). e39368–e39368. 9 indexed citations

14.

Woollard, David J., Catriona McLean, Scott Preiss, et al.. (2011). Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. Journal of Hepatology. 55(3). 536–544. 15 indexed citations

15.

Li, Shuo. (2009). Ethidium Bromide Fluorescence Probe on the Interaction between Dinuclear Macrocyclic Polyamine Zn(II) Complex and DNA. Chinese Journal of Applied Chemistry. 3 indexed citations

16.

Martyn, John C., Bruce D. Wines, Shuo Li, et al.. (2009). Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Archives of Virology. 154(7). 1129–1138. 33 indexed citations

17.

Li, Shuo, Kathryn Jones, David J. Woollard, et al.. (2007). Defining target antigens for CD25⁺FOXP3⁺IFN‐γ⁻ regulatory T cells in chronic hepatitis C virus infection. Immunology and Cell Biology. 85(3). 197–204. 55 indexed citations

18.

Li, Shuo, Eric J. Gowans, Claire Chougnet, Magdalena Plebanski, & Ulf Dittmer. (2007). Natural Regulatory T Cells and Persistent Viral Infection. Journal of Virology. 82(1). 21–30. 125 indexed citations

19.

Martyn, John C., et al.. (2006). Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus. Archives of Virology. 152(2). 329–343. 11 indexed citations

20.

Tipping, Peter G., et al.. (1997). Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney International. 51(1). 94–103. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact